| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |